Formost 6mcg/400mcg Novocart is a combination of two medicines: Formoterol and Mometasone. Formoterol and mometasone. Formoterol is a long-acting bronchodilator which works by relaxing the muscles in the airways and widens the airways. Mometasone is a corticosteroid. It acts by stopping the release of certain natural substances in body that are responsible for inflammation of the airways. Together, they make breathing easier.
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Formost 6mcg/400mcg Novocart may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Formost 6mcg/400mcg Novocart is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Formost 6mcg/400mcg Novocart may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Formost 6mcg/400mcg Novocart is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Formost 6mcg/400mcg Novocart may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Formost 6mcg/400mcg Novocart in patients with liver disease. Please consult your doctor.
What were the side-effects while using Formost 6mcg/400mcg Novocart?
How do you take Formost Novocart?
With or without food
How much was the improvement?
Please rate Formost 6mcg/400mcg Novocart on price
What are you using Formost Novocart for?
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Formost 6mcg/400mcg Novocart. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 1st Dec 2017.